Clinical Trial Update: Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bone marrow mononuclear cells with atorvastatin to enhance transplantation effects in myocardial infarction; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Myocardial Infarction, Stem Cell Transplantation | Phase 2 | Status: COMPLETED